Number of the records: 1  

A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models

  1. 1.
    0481621 - ÚEM 2018 RIV GB eng J - Journal Article
    Tyzack, G.E. - Hall, E.C. - Sibley, Ch.R. - Cymes, T. - Forostyak, Serhiy - Carlino, G. - Meyer, I.F. - Schiavo, G. - Zhang, S.Ch. - Gibbons, G.M. - Newcombe, J. - Patani, R. - Lakatos, A.
    A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models.
    Nature Communications. Roč. 8, oct. (2017), s. 1164. E-ISSN 2041-1723
    R&D Projects: GA ČR(CZ) GA17-21146S
    Institutional support: RVO:68378041
    Keywords : amyotrophic-lateral-sclerosis * facial motor nucleus * spinal-cord-injury
    OECD category: Neurosciences (including psychophysiology
    Impact factor: 12.353, year: 2017

    Astrocyte responses to neuronal injury may be beneficial or detrimental to neuronal recovery, but the mechanisms that determine these different responses are poorly understood. Here we show that ephrin type-B receptor 1 (EphB1) is upregulated in injured motor neurons, which in turn can activate astrocytes through ephrin-B1-mediated stimulation of signal transducer and activator of transcription-3 (STAT3). Transcriptional analysis shows that EphB1 induces a protective and anti-inflammatory signature in astrocytes, partially linked to the STAT3 network. This is distinct from the response evoked by interleukin (IL)-6 that is known to induce both pro inflammatory and anti-inflammatory processes. Finally, we demonstrate that the EphB1-ephrin-B1 pathway is disrupted in human stem cell derived astrocyte and mouse models of amyotrophic lateral sclerosis (ALS). Our work identifies an early neuronal help-me signal that activates a neuroprotective astrocytic response, which fails in ALS, and therefore represents an attractive therapeutic target.
    Permanent Link: http://hdl.handle.net/11104/0277154

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.